Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |